tiprankstipranks
Kinnate Biopharma (KNTE)
NASDAQ:KNTE

Kinnate Biopharma (KNTE) Financial Statements

233 Followers

Kinnate Biopharma Financial Overview

Kinnate Biopharma's market cap is currently ―. The company's EPS TTM is $-2.776; its P/E ratio is -0.96; Kinnate Biopharma is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -30.73M$ -31.92M$ -34.65M$ -32.73M$ -31.37M
EBITDA-$ -32.86M$ -35.19M$ -32.84M$ -31.19M
Net Income Common Stockholders$ -30.73M$ -31.92M$ -32.94M$ -31.61M$ -30.74M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 167.58M$ 184.70M$ 200.98M$ 227.20M$ 230.98M
Total Assets$ 190.71M$ 216.18M$ 243.88M$ 278.83M$ 302.13M
Total Debt$ 3.38M$ 3.70M$ 3.95M$ 4.18M$ 4.42M
Net Debt$ -164.19M$ -181.00M$ -197.03M$ -223.02M$ -226.56M
Total Liabilities$ 18.29M$ 18.52M$ 21.12M$ 20.36M$ 18.79M
Stockholders Equity$ 172.42M$ 197.64M$ 222.76M$ 223.47M$ 248.34M
Cash Flow-
Free Cash Flow-$ -29.41M$ -27.73M$ -23.84M$ -20.72M
Operating Cash Flow$ -25.54M$ -29.42M$ -27.72M$ -23.75M$ -20.66M
Investing Cash Flow$ 42.63M$ -10.88M$ 55.42M$ 17.57M$ 16.96M
Financing Cash Flow$ 57.00K$ 1.25M$ -9.12M$ 193.00K$ 190.00K
Currency in USD

Kinnate Biopharma Earnings and Revenue History

Kinnate Biopharma Debt to Assets

Kinnate Biopharma Cash Flow

Kinnate Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis